Status and phase
Conditions
Treatments
About
This study will be conducted to assess the effect of severe renal impairment on the pharmacokinetics of lemborexant after a single-dose administration.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Inclusion Criteria for All Participants:
Additional Inclusion Criteria for Healthy Participants:
Additional Inclusion Criteria for Participants with Renal Impairment:
Exclusion criteria
Exclusion Criteria for All Participants:
Additional Exclusion Criteria for Healthy Participants:
Additional Exclusion Criteria for Participants With Renal Impairment:
Primary purpose
Allocation
Interventional model
Masking
16 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal